GenHealth.ai
Use Cases
Products
Company
Research
Get a Demo
See how we Automate Prior Authorization
Use our Population Health Analytics Co-pilot
Search all medical codes
T45.95XA
Adverse effect of unspecified primarily systemic and hematological agent, initial encounter
ICD10CM code
Medical Policies and Guidelines for Adverse effect of unspecified primarily systemic and hematological agent, initial encounter
Related policies from health plans
ANTHEM-BLUECROSS-CA
Selected Injectable 5HT3 Antiemetic Agents
OSCAR
Varubi (rolapitant) (PG178)
CIGNA
Transthoracic Echocardiography in Children - (0523)
Similar Codes
ICD10CM codes
T45.95XA
- Adverse effect of unspecified primarily systemic and hematological agent, initial encounter
T45.95XD
- Adverse effect of unspecified primarily systemic and hematological agent, subsequent encounter
T45.8X5A
- Adverse effect of other primarily systemic and hematological agents, initial encounter
T45.95
- Adverse effect of unspecified primarily systemic and hematological agent
T45.8X5D
- Adverse effect of other primarily systemic and hematological agents, subsequent encounter
T45.95XS
- Adverse effect of unspecified primarily systemic and hematological agent, sequela
T45.94XA
- Poisoning by unspecified primarily systemic and hematological agent, undetermined, initial encounter
T45.8X5
- Adverse effect of other primarily systemic and hematological agents
T46.905A
- Adverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounte
T45.96XA
- Underdosing of unspecified primarily systemic and hematological agent, initial encounter
HCPCS codes
G8952
- Pre-hypertensive or hypertensive blood pressure reading documented, indicated follow-up not document
J7599
- Immunosuppressive drug, not otherwise classified
J3485
- Injection, zidovudine, 10 mg
G9929
- Patient with transient or reversible cause of af (e.g., pneumonia, hyperthyroidism, pregnancy, cardi
G9597
- Pediatric patient with minor blunt head trauma not classified as low risk according to the pecarn pr
D9450
- CASE PRESENTATION
J9181
- Injection, etoposide, 10 mg
G9842
- Patient has metastatic disease at diagnosis
J9000
- Injection, doxorubicin hydrochloride, 10 mg
C9476
- Injection, daratumumab, 10 mg
CPT4 codes
85999
- Unlisted hematology and coagulation procedure
95199
- Unlisted allergy/clinical immunologic service or procedure
96549
- Unlisted chemotherapy procedure
86999
- Unlisted transfusion medicine procedure
38999
- Unlisted procedure, hemic or lymphatic system
86162
- Complement; total hemolytic (CH50)
86849
- Unlisted immunology procedure
96379
- Unlisted therapeutic, prophylactic, or diagnostic intravenous or intra-arterial injection or infusio
86153
- Cell enumeration using immunologic selection and identification in fluid specimen (eg, circulating t
42961
- Control oropharyngeal hemorrhage, primary or secondary (eg, post-tonsillectomy); complicated, requir
Choose how you'd like to learn more
Email
Send us a message or questions and we can share more details.
Name
Email
Message
Company Name
Submit
Meet
Setup a calendar meeting with us; find a time now.
DIY Demo
Sign up for a free account to see our product in action.
Demo Gen AI Healthcare Analytics